IBEX Nasdaq Services-Computer Processing & Data Preparation Financials FY2021βFY2026
IBEX Ltd had $644M of revenue in fiscal 2026, up 15.4% on the year before. Over five years, revenue changed +7.8% a year on average.
Last close Β· Oct 23, 2026
$47.23
0.6%Hi! I read IBEX Ltdβs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
+15.4%
Yes. Sales grew 15.4% last year.
Does it make a profit?
7.2%
A little. It keeps 7.2% of every sale as profit.
Does profit turn into cash?
4.8%
Partly. 4.8% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
8 / 8
Solid. It passes 8 of 8 health tests.
How is the share priced?
15.1x
One share costs 15.1 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· IBEX Ltd had $644M of revenue in fiscal 2026, up 15.4% on the year before. Over five years, revenue changed +7.8% a year on average. Its operating margin was 8.5%, up 0.2Β pts: of every 100 in sales, about 9 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· IBEX Ltd made $46.3M of net profit in fiscal 2026. From fiscal 2021 to 2026, diluted EPS grew 34.5% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $31.2M in fiscal 2026, 4.8% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· IBEX Ltd returned $14.4M to shareholders in fiscal 2026, 46% of free cash flow. The diluted share count fell 5.8%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders sold $5.9M of shares on the open market and bought none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$5.9M
11 insiders
Of sales under plans
39%
$2.3M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold plan | 5,000 | $45.02 | $0.2M | Form 4 |
| Sep 16, 2026 | Paul Joseph InsonChief People Officer | Sold | 2,500 | $40.07 | $0.1M | Form 4 |
| Sep 16, 2026 | Christina Alice Trofimuk-O'ConnorChief Legal Officer | Sold | 2,376 | $39.34 | $0.1M | Form 4 |
| Sep 15, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold | 25,000 | $39.99 | $1.0M | Form 4 |
| Sep 15, 2026 | Christina Alice Trofimuk-O'ConnorChief Legal Officer | Sold | 7,500 | $40.30 | $0.3M | Form 4 |
| Sep 15, 2026 | Daniella Ballou-AaresDirector | Sold | 1,500 | $40.29 | $0.1M | Form 4 |
| Sep 15, 2026 | Mingzhe ZhuangDirector | Sold | 5,522 | $40.10 | $0.2M | Form 4 |
| Sep 15, 2026 | Julie K CasteelChief Sales/Marketing Officer | Sold | 17,474 | $40.41 | $0.7M | Form 4 |
| Sep 14, 2026 | Paul Joseph InsonChief People Officer | Sold plan | 2,274 | $40.00 | $0.1M | Form 4 |
| Sep 14, 2026 | David Martin AfdahlChief Operating Officer | Sold plan | 10,819 | $40.07 | $0.4M | Form 4 |
| Sep 8, 2026 | David Martin AfdahlChief Operating Officer | Sold plan | 17,500 | $37.09 | $0.6M | Form 4 |
| Jun 11, 2026 | Julie K CasteelChief Sales/Marketing Officer | Sold | 3,600 | $30.61 | $0.1M | Form 4 |
| May 28, 2026 | Patrick McGinnisDirector | Sold | 1,030 | $31.69 | $0.0M | Form 4 |
| May 22, 2026 | Taylor C GreenwaldChief Financial Officer | Sold | 964 | $32.02 | $0.0M | Form 4 |
| May 13, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold | 7,800 | $30.50 | $0.2M | Form 4 |
| May 12, 2026 | Bruce Neil DawsonChief Sales and CS Officer | Sold | 15,260 | $31.12 | $0.5M | Form 4 |
| May 11, 2026 | Bruce Neil DawsonChief Sales and CS Officer | Sold | 3,129 | $32.80 | $0.1M | Form 4 |
| Feb 23, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold plan | 6,000 | $28.46 | $0.2M | Form 4 |
| Feb 20, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold plan | 6,000 | $29.40 | $0.2M | Form 4 |
| Feb 19, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold plan | 6,000 | $29.73 | $0.2M | Form 4 |
| Feb 18, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold plan | 6,000 | $29.98 | $0.2M | Form 4 |
| Feb 17, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold plan | 6,000 | $29.63 | $0.2M | Form 4 |
| Feb 6, 2026 | Michael Joseph DarwalChief AI & Digital Officer | Sold | 1,660 | $34.98 | $0.1M | Form 4 |
| Feb 6, 2026 | Paul Joseph InsonChief People Officer | Sold | 2,627 | $34.98 | $0.1M | Form 4 |
| Dec 2, 2025 | Daniella Ballou-AaresDirector | Sold | 500 | $35.01 | $0.0M | Form 4 |
| Oct 2, 2025 | Robert Thomas DechantChief Executive Officer, Director | Sold | 6,711 | $39.58 | $0.3M | Form 4 |
| Oct 2, 2025 | Christina Alice Trofimuk-O'ConnorChief Legal Officer | Sold | 1,001 | $39.58 | $0.0M | Form 4 |
| Oct 2, 2025 | Paul Joseph InsonChief People Officer | Sold | 697 | $39.58 | $0.0M | Form 4 |
| Oct 2, 2025 | David Martin AfdahlChief Operating Officer | Sold | 1,103 | $39.58 | $0.0M | Form 4 |
| Oct 2, 2025 | Julie K CasteelChief Sales/Marketing Officer | Sold | 806 | $39.58 | $0.0M | Form 4 |
| Oct 2, 2025 | Taylor C GreenwaldChief Financial Officer | Sold | 1,275 | $39.58 | $0.1M | Form 4 |
| Oct 2, 2025 | Bruce Neil DawsonChief Sales and CS Officer | Sold | 959 | $39.58 | $0.0M | Form 4 |
| Mar 13, 2025 | Daniella Ballou-AaresDirector | Sold | 6,000 | $24.22 | $0.1M | Form 4 |
Can it carry its debts, and how well does it use its money?
KIRA Β· IBEX Ltd has $28.4M more cash than debt.
Cash, debt and the ratios that show how comfortably IBEX Ltd can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $48.8M | $57.4M | $62.7M | $15.4M | $32.6M |
| Debt incl. finance leases | $16.5M | $2.0M | $3.7M | $4.1M | $4.2M |
| Net debt / EBITDA | β0.8x | β0.9x | β1.0x | β0.2x | β0.4x |
| Debt / equity | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 16.0x | 51.1x | 76.7x | 28.5x | 58.7x |
| Current ratio | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Quick ratio | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Total assets | $294M | $293M | $294M | $273M | $309M |
| Total liabilities | $181M | $143M | $128M | $139M | $139M |
| Shareholders' equity | $113M | $150M | $166M | $134M | $170M |
| Net debt (β = net cash) | β$32.4M | β$55.5M | β$59.0M | β$11.3M | β$28.4M |
KIRA Β· Its return on capital was 33.5%: every 100 invested in the business earned about 33 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· IBEX Ltd passes 8 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 7 / 8 | 6 / 8 | 6 / 8 | 8 / 8 |
| Accruals ratio | β | β6.3% | β3.5% | β0.8% | β3.1% | β4.4% |
| Altman Z'' | β | 1.28 | 3.44 | 4.57 | 4.05 | 5.24 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $443M | $493M | $523M | $509M | $558M | $644M |
| Operating income | $17.0M | $20.6M | $40.5M | $39.4M | $46.6M | $55.0M |
| Interest expense | $1.9M | $1.3M | $0.8M | $0.5M | $1.6M | $0.9M |
| Pretax income | $15.2M | $19.4M | $40.3M | $41.0M | $45.9M | $54.3M |
| Income tax | $2.1M | β$2.1M | $8.7M | $7.3M | $9.1M | $8.0M |
| Net income | $13.1M | $21.5M | $31.6M | $33.7M | $36.9M | $46.3M |
| Net income to common | β | β | $31.6M | $33.7M | $36.9M | $46.3M |
| Diluted EPS | $0.71 | $1.15 | $1.67 | $1.84 | $2.36 | $3.13 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.01B |
| Cash flow | ||||||
| Cash from operations | $16.1M | $40.0M | $41.9M | $35.9M | $45.7M | $59.0M |
| Capital expenditure | $20.8M | $25.9M | $19.0M | $8.9M | $18.4M | $27.8M |
| Free cash flow | β$4.7M | $14.1M | $22.9M | $27.0M | $27.3M | $31.2M |
| Depreciation and amortization | $14.1M | $18.1M | $19.0M | $19.5M | $17.2M | $19.9M |
| Stock-based compensation | $5.4M | $1.9M | $4.6M | $3.8M | $5.4M | $7.7M |
| Share buybacks | $0.0M | $3.4M | $0.3M | $21.6M | $78.0M | $14.4M |
| Dividends paid | $4.0M | $0.0M | $0.0M | β | β | β |
| Dividends and buybacks | $4.0M | $3.4M | $0.3M | $21.6M | $78.0M | $14.4M |
| Balance sheet | ||||||
| Cash and short-term investments | $57.8M | $48.8M | $57.4M | $62.7M | $15.4M | $32.6M |
| Total debt | β | $15.7M | $1.0M | $2.2M | $2.4M | $2.5M |
| Finance lease liabilities | β | $0.7M | $1.0M | $1.5M | $1.6M | $1.7M |
| Current assets | β | $142M | $159M | $180M | $146M | $180M |
| Current liabilities | β | $97.8M | $73.3M | $71.0M | $79.9M | $85.5M |
| Goodwill | β | $11.8M | $11.8M | $11.8M | $11.8M | $11.8M |
| Total assets | β | $294M | $293M | $294M | $273M | $309M |
| Total liabilities | β | $181M | $143M | $128M | $139M | $139M |
| Shareholders' equity | $94.7M | $113M | $150M | $166M | $134M | $170M |
| Margins | ||||||
| Operating margin | 3.8% | 4.2% | 7.7% | 7.8% | 8.3% | 8.5% |
| EBITDA margin | 7.0% | 7.9% | 11.4% | 11.6% | 11.4% | 11.6% |
| Net margin | 3.0% | 4.4% | 6.0% | 6.6% | 6.6% | 7.2% |
| FCF margin | β1.1% | 2.9% | 4.4% | 5.3% | 4.9% | 4.8% |
| Returns | ||||||
| Return on capital | β | 25.7% | 33.9% | 30.8% | 30.8% | 33.5% |
| Return on capital employed | β | 10.5% | 18.4% | 17.7% | 24.1% | 24.6% |
| Return on equity | 13.8% | 20.6% | 24.0% | 21.3% | 24.6% | 30.4% |
| Return on assets | β | 7.3% | 10.8% | 11.5% | 13.0% | 15.9% |
| Return on tangible equity | 13.8% | 21.1% | 22.9% | 21.9% | 30.1% | 29.2% |
| Growth | ||||||
| Revenue growth | β | 11.2% | 6.1% | β2.8% | 9.8% | 15.4% |
| Net income growth | β | 63.9% | 47.2% | 6.6% | 9.5% | 25.7% |
| EPS growth | β | 62.0% | 45.2% | 10.2% | 28.3% | 32.6% |
| FCF growth | β | β | 62.6% | 18.1% | 0.9% | 14.3% |
| Share count change | β | 2.0% | 0.9% | β3.4% | β13.9% | β5.8% |
| Financial health | ||||||
| Net debt / EBITDA | β | β0.8x | β0.9x | β1.0x | β0.2x | β0.4x |
| Debt / equity | β | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 9.0x | 16.0x | 51.1x | 76.7x | 28.5x | 58.7x |
| Current ratio | β | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Quick ratio | β | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Capital allocation | ||||||
| Capex / revenue | 4.7% | 5.3% | 3.6% | 1.7% | 3.3% | 4.3% |
| Stock comp / revenue | 1.2% | 0.4% | 0.9% | 0.7% | 1.0% | 1.2% |
| Payouts / FCF | β | 24.2% | 1.2% | 79.7% | 285.8% | 46.1% |
| Quality scores | ||||||
| Piotroski F-score | β | β | 7.0 | 6.0 | 6.0 | 8.0 |
| Altman Z'' | β | 1.3 | 3.4 | 4.6 | 4.0 | 5.2 |
| Accruals ratio | β | β6.3% | β3.5% | β0.8% | β3.1% | β4.4% |
Source: SEC EDGAR XBRL filings (CIK 0001720420). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
